Jung-hwan Y. Yoon
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 286 publications
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.
Journal: Cancer immunology, immunotherapy : CII
Published: November 18, 2025
Associations between changes in MASLD status and cancer development in young adults: A nationwide cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 04, 2025
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
Journal: Gut and liver
Published: September 29, 2025
Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study.
Journal: Diabetes, obesity & metabolism
Published: September 05, 2025
Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: August 22, 2025
Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis.
Journal: Clinical and molecular hepatology
Published: May 19, 2025
Associations between steatotic liver disease subtypes and incident atrial fibrillation in young adults: a nationwide cohort study.
Journal: Cardiovascular diabetology
Published: April 27, 2025
Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.
Journal: Liver cancer
Published: April 15, 2025
Prognostic Impact of Varices and Hemorrhagic Events in Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab.
Journal: Gut and liver
Published: March 19, 2025
Comparison of Annual Dynamic Abbreviated MRI and Biannual Ultrasound for HCC Surveillance in a High-Risk Group: Two-Center Cohort Study.
Journal: Liver cancer
Published: March 18, 2025
Last Updated: 09/26/2026